ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Vertex Pharmaceuticals Incorporated clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 295 studies whose lead sponsor is Vertex Pharmaceuticals Incorporated or one of 6 companies grouped under it. 20 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 17, 2026.

Our grouping of 7 registry names, not the registry’s. See them and correct one ↓

Compare Vertex Pharmaceuticals with Jiangsu HengRui Medicine and Eli Lilly →

Pipeline: 18 programs

Each counted once: 18 with a study Vertex Pharmaceuticals Incorporated leads registered in the last two years.

  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4 (approved, new studies)

The 5 of 8 with the most live studies.

Program
povetaciceptPhase 3 · 6 live · Glomerulonephritis, IGA · primary completion Dec 2027☆ Track
tezacaftorVX661Phase 3 · 4 live · Cystic Fibrosis · primary completion Apr 2027☆ Track
atumelnantPhase 3 · 3 live · Adrenal Hyperplasia, Congenital · primary completion May 2027☆ Track
PaltusotinePhase 3 · 1 live · Acromegaly · primary completion Aug 2027☆ Track
inaxaplinVX147Phase 3 · 1 live · Glomerulosclerosis, Focal Segmental · primary completion Jun 2028☆ Track

3 more in phase 3 — sign in to see them all, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Vertex Pharmaceuticals Incorporated’s own registered studies; Vertex Pharmaceuticals Incorporated’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Vertex Pharmaceuticals Incorporated’s studies test, most open studies first — 40 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 20 more

The first 30 of 40; every drug is on its own page, and each page lists its sponsors.

Coming up

21 of Vertex Pharmaceuticals Incorporated’s studies under way reach primary completion within a year, 10 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. 2D
  3. 1J’27
  4. 1F
  5. 4M
  6. 2A
  7. 2M
  8. 3J
  9. 2J
  10. 2A
  11. 1S
  12. O
  13. 1N

The 12 nearest

Show 7 more

Add all 21 to your calendar (.ics) → With an account.

All 295 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now207%Recruiting 16 · Enrolling by invitation 4
  • Under way, not recruiting186%
  • Completed22376%
  • Stopped early2910%Terminated 27 · Withdrawn 2
  • Status unknown or other52%Approved for marketing 4 · Status unknown 1

Phase

Where

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 2622
  17. 23
  18. 24
  19. 25
  20. 1426

By the year each study started; 13 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Vertex Pharmaceuticals Incorporated.

  • Vertex Pharmaceuticals Incorporated
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    249 studies
  • Crinetics Pharmaceuticals Inc.
    Acquired — became part of Vertex Pharmaceuticals Incorporated, Sep 1, 2026 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    19 studies →
  • Nivalis Therapeutics, Inc.
    Acquired — became part of Vertex Pharmaceuticals Incorporated, May 18, 2024 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    11 studies →
  • Alpine Immune Sciences, Inc.
    Acquired — became part of Vertex Pharmaceuticals Incorporated, May 18, 2024 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    7 studies →
  • ViaCyte
    Acquired — became part of Vertex Pharmaceuticals Incorporated, Sep 27, 2022 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    5 studies →
  • Alpine Immune Sciences Inc, A Subsidiary of Vertex
    Acquired — became part of Vertex Pharmaceuticals Incorporated, May 18, 2024 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    3 studies →
  • Novocell
    Acquired — became part of Vertex Pharmaceuticals Incorporated, Sep 27, 2022 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Focus areas

Conditions Vertex Pharmaceuticals Incorporated leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 295. Browse all 295 →